News

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond to or cannot receive topical corticosteroids, Leo Pharma announced in a ...
Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...
LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...
A new way of treating common inflammatory skin conditions such as eczema is on the horizon, according to a new study.
Pi De Kang Dermatitis Cream was supplied by TCM clinic chain Chinese Medical Centre as a “skin itching cream”. Read more at straitstimes.com. Read more at straitstimes.com.